To ask the Secretary of State for Health and Social Care, with reference to the findings of LOGEX’s International Comparison Medicines Uptake 2021 report to NHS England & NHS Improvement, published in December 2021, what assessment his Department has made of the effect of the capacity available in the severe asthma centres on levels of uptake of severe asthma biologics.
25 April 2022
No specific assessment has been made. NHS England and NHS Improvement’s Severe Asthma Collaborative are developing the capacity of the severe asthma centres to streamline patient pathways to biologic therapy and reduce variation in prescribing and patient management. A toolkit has been produced to support clinical teams.